Living our purpose through the pandemic

Clients and members
  • Over 1 million tests conducted
  • R868 million paid for tests
  • Over 100 000 cumulative admissions
  • Approximately 15 000 total deaths
  • R11.5 billion paid for COVID-19 related admissions

A WhatsApp solution was rolled out to medical scheme members as an additional communication and self-help platform to educate members and update them on the current status of the COVID-19 pandemic

Shareholders

Operating profit increased by 15.5%, representing Compound annual growth rate (CAGR) of 24.4% since 2016

Operating profit increased by 15.5%,
representing Compound

Sustained net cash position with a positive return on equity

CAGR of 24.4% (2016 to 2021)

Employees

R17 million invested in enabling employees to work remotely

Our people have shown tremendous resilience. At year-end, 21% of our staff were working remotely while still maintaining our service levels

Community

The VirtualCareTM application was rolled out, enabling medical scheme members to consult with healthcare providers using a telehealth platform. In addition, free virtual COVID-19 consultations were offered to all South Africans through VirtualCarTM

4 webinars hosted for the clinical community relating to COVID-19 and the vaccination process

10 000 medical-grade masks supplied for nursing members of the Democratic Nursing Organisation of South Africa

Provided COVID-19 rapid testing stations at two major South African airports

Fast-tracking the vaccination process

The Group mobilised a national network of over 3 000 nurses to vaccinate eligible scheme members

190 082 vaccinations administered
6 vaccination sites
R31 million spent on vaccination roll out

"We take our responsibility as a leader in healthcare seriously. We are committed to doing all we can to protect our members, enable the response of the healthcare industry, and the country at large – especially at this challenging and uncertain time."
AfroCentric Group CEO, Ahmed Banderker